Clinical Trial

Effect of Sensory Integration Therapy on Gait Variability and Quality Of Life in Patients With Multiple Sclerosis

Completed
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the impact of sensory integration therapy on individuals with multiple sclerosis (MS) by examining its effects on gait variability and overall quality of life.
Protocol Amendment History 3 changes
critical Completed without a posted recruiting period 2026-08-06
critical Primary endpoint(s) modified 2026-08-06
notable Enrollment reduced: 44 -> 38 participants 2026-08-06
Trial Details
NCT Number NCT07390201
Lead Sponsor Cairo University
Conditions Multiple Sclerosis
Enrollment 38 participants
Start Date 2026-02-05
Primary Completion 2026-07-20 (estimated)
Study Completion 2026-07-20 (estimated)
Updated on ClinicalTrials.gov 2026-08-05